Treatment of Acetaminophen (Koffex) Overdose
N-acetylcysteine (NAC) is the definitive treatment for acetaminophen overdose and should be administered promptly to all patients with suspected acetaminophen toxicity to prevent liver damage and reduce mortality. 1
Initial Management
- For patients presenting within 4 hours of ingestion, administer activated charcoal prior to starting NAC to reduce drug absorption 1
- Contact a liver transplant center early in the evaluation process for patients with signs of acute liver failure 1
- Obtain acetaminophen levels in all patients presenting with acute liver failure, even when history is lacking, as very high aminotransferases (>3,500 IU/L) strongly correlate with acetaminophen poisoning 1
- Seek immediate medical help or contact a poison control center (1-800-222-1222) in case of overdose 2
Indications for NAC Treatment
- Patients with acetaminophen levels above the treatment line on the Rumack-Matthew nomogram 1, 3
- Patients with known or suspected acetaminophen ingestion with rising aminotransferases indicating evolving liver injury 1
- Patients with acute liver failure where acetaminophen ingestion is possible or circumstances surrounding admission are unclear 1
- Patients with hepatotoxicity due to acetaminophen, including cases of repeated supratherapeutic ingestions 1
NAC Administration Routes
Oral Administration
- Loading dose: 140 mg/kg diluted to 5% solution 1
- Maintenance dose: 70 mg/kg every 4 hours for 17 doses 1
- Side effects: occasional nausea, vomiting, rare urticaria or bronchospasm 1
Intravenous Administration (when oral route is contraindicated)
- Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1
- First maintenance dose: 50 mg/kg over 4 hours 1
- Second maintenance dose: 100 mg/kg over 16 hours 1
- Consider IV route in patients with gastrointestinal bleeding, worsening mental status, or other contraindications to oral administration 1
Special Considerations
- NAC is most effective when given early but may still provide benefit when administered 48 hours or more after ingestion 1
- For patients with unknown time of ingestion or unreliable history, consider NAC treatment if acetaminophen is detectable in serum or transaminases are elevated 1
- For extended-release formulations or repeated supratherapeutic ingestions, standard nomograms may not apply; consider NAC treatment based on clinical judgment 1, 4
- NAC has been shown to reduce mortality, cerebral edema, and need for inotropic support in patients with acetaminophen-induced hepatic failure 1
Monitoring and Supportive Care
- Monitor patients frequently, preferably in an ICU setting for those with acute liver failure 1
- Allergic reactions to NAC may be treated with discontinuation, antihistamines, and epinephrine for bronchospasm 1
- Supportive care remains crucial, with focus on maintaining airway, ventilation, and circulation while the drug is eliminated 5
Risk Factors for Increased Toxicity
- Chronic alcohol consumption increases risk of hepatotoxicity, even with lower acetaminophen doses 3
- Pre-existing liver disease may increase susceptibility to acetaminophen toxicity 3
- Fasting states may alter acetaminophen metabolism, increasing toxicity risk 1
Prognosis
- Early NAC administration significantly improves outcomes 1
- Without NAC treatment, patients with acetaminophen-induced hepatic failure have higher mortality rates (80% vs 52% with NAC) 1
- NAC treatment reduces progression to coma and need for dialysis in patients with hepatic failure 1
Remember that acetaminophen overdose is the leading cause of acute liver failure in Western countries, but with prompt recognition and appropriate NAC treatment, most patients survive with complete recovery 4.